Your browser doesn't support javascript.
loading
Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann, Elisabeth; Bucher, Heiner C; Jaeckel, Steffen; Gibbons, Sara; McAllister, Katie; Scherrer, Alexandra U; Braun, Dominique L; Cavassini, Matthias; Hachfeld, Anna; Calmy, Alexandra; Battegay, Manuel; Cipriani, Michela; Elzi, Luigia; Young, James; Lopez-Centeno, Beatriz; Berenguer, Juan; Khoo, Saye; Moffa, Giusi; Marzolini, Catia.
Afiliação
  • Deutschmann E; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Bucher HC; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Jaeckel S; Division of Infectious Diseases and Hospital Hygiene, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Gibbons S; EYE T services, Freiburg, Germany.
  • McAllister K; Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Scherrer AU; Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.
  • Braun DL; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Switzerland.
  • Cavassini M; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Hachfeld A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Switzerland.
  • Calmy A; Division of Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland.
  • Battegay M; Department of Infectious Diseases, University Hospital Bern and University of Bern, Bern, Switzerland.
  • Cipriani M; Division of Infectious Diseases, University Hospital Geneva, Geneva, Switzerland.
  • Elzi L; Division of Infectious Diseases and Hospital Hygiene, University Hospital Basel and University of Basel, Basel, Switzerland.
  • Young J; Division of Infectious Diseases and Hospital Epidemiology, Canton Hospital St Gallen, St Gallen, Switzerland.
  • Lopez-Centeno B; Ospedale Regionale di Bellinzone e Valli, Bellinzona, Switzerland.
  • Berenguer J; Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Khoo S; Subdirección General de Farmacia y Productos Sanitarios. Servicio Madrileño de Salud (SERMAS), Madrid, Spain.
  • Moffa G; Hospital General Universitario Gregorio Marañón (IiSGM), Madrid, Spain.
  • Marzolini C; Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.
Clin Infect Dis ; 73(7): e2145-e2152, 2021 10 05.
Article em En | MEDLINE | ID: mdl-32634832
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Infecções por HIV / Inibidores de Integrase de HIV Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Infecções por HIV / Inibidores de Integrase de HIV Idioma: En Ano de publicação: 2021 Tipo de documento: Article